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Although this study breaks important 
new ground, it will be useful to further 
verify this effect in the more complex envi-
ronment found inside cells. A key experi-
ment will be to analyze the effect of inositol 
phospholipids, such as PIP2, on this pro-
cess given that they regulate both Arp2/3-
activating proteins (such as N-WASP) and 
capping protein. It will also be exciting to 
see these ideas incorporated into future 
biophysical models of actin polymeriza-
tion-induced force generation.
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Among its multiple functions, p53 is a critical regulator of TGF-β responses. Sasai et al. (2008) 
now identify a new p53 inhibitory protein, XFDL156. During embryonic development, this factor 
is expressed in the ectoderm germ layer and maintains the pluripotency of ectodermal cells by 
inhibiting TGF-β target genes that promote mesoderm specification.The signals delivered by members of 
the transforming growth factor β (TGF-β) 
protein family are central to the specifi-
cation of germ cell identity in embryonic 
development. In the endoderm, mater-
nal factors activate the expression of 
TGF-β ligands that in turn induce over-
lying cells to become mesoderm (Figure 
1). Yet, how this induction remains con-
fined to cells lying at the equator of the 
embryo leaving the ectoderm pluripotent 
remains unclear (Niehrs, 2004). Recent 
embryological and molecular evidence 
argues that the development of a pluri-
potent ectoderm appears to result from 
an active molecular process in which 
cells constantly keep TGF-β signaling 
in check. For example, prior to gastrula-
tion, the embryo requires an ectoderm-
specific maternal determinant, Ecto-
dermin/Tif1γ, that ubiquitinates Smad4, 
inhibiting its activity (Dupont et al., 
2005). At the end of gastrulation, once germ layers have been induced, TGF-β 
then takes on other duties. At the gas-
trula stage, TGF-β ligands signal through 
Smad2 to start dividing the ectoderm 
into neural and non-neural territories 
along the dorsoventral axis (Figure 1) 
(Chang and Harland, 2007). Paradoxi-
cally, this event is not temporally isolated 
from mesoderm induction (Camus et al., 
2006). It is unclear how embryos seam-
lessly orchestrate what appear to be 
diametrically opposing needs: avoiding 
TGF-β-mediated transformation of the 
ectoderm into mesoderm while at the 
same time using TGF-β for ectodermal 
patterning.
The work of Sasai et al. (2008) in this 
issue of Cell provides an elegant solution 
to this conundrum (Sasai et al., 2008). 
They clone, from the frog Xenopus, a 
new ectoderm-specific gene encod-
ing XFDL156, which has the remarkable 
capacity to uncouple TGF-β responses Cell 1from mesodermal differentiation. The 
real surprise and excitement about this 
discovery comes from its mechanism of 
action—XFDL156 is a new antagonist of 
the p53 tumor suppressor that leaves the 
TGF-β/Smad pathway operational.
Expression cloning in Xenopus 
embryos was the route taken to this 
discovery (Smith and Harland, 1992). It 
is remarkable that in the era of short-
interfering RNA (siRNA) libraries and 
genome-wide mutagenesis screens, 
this straightforward and purely gain-of-
function approach continues to uncover 
some of the most interesting new 
genes, suggesting that we are still far 
from saturation. As in any screen, the 
experimental strategy is critical. Sasai 
et al. searched almost 20,000 genes 
specifically expressed at the end of 
gastrulation and assayed for those able 
to inhibit TGF-β induction of mesoderm 
in explanted ectoderm cells.33, May 30, 2008 ©2008 Elsevier Inc. 767
Members of the p53 family 
are integral elements in many 
TGF-β gene responses. The 
p53 tumor suppressor binds 
to Smad2 to form transcrip-
tional cooperating complexes 
required for the activation of 
multiple mesodermal genes 
in Xenopus embryos and for 
the deployment of the TGF-β 
cytostatic program in mam-
malian cells (Cordenonsi et 
al., 2003). Unlike the case 
in mouse embryos, p53 
is the only family member 
expressed at early stages of 
Xenopus development. This 
has greatly facilitated the dis-
section of the p53 pathway in 
frog embryos microinjected 
with anti-p53 morpholino oli-
gonucleotides (Cordenonsi et 
al., 2003). Sasai et al. (2008) 
show that overexpression 
of XFDL156 blocks meso-
derm differentiation in whole 
embryos, phenocopying p53 inactiva-
tion. Conversely, loss of XFDL156 reca-
pitulates p53 gain of function, converting 
embryonic territories that would normally 
develop as ectoderm into mesoderm. In 
these assays, p53 mediates the effect 
of XFDL156 and, notably, neither Smad 
localization nor activity is involved. Using 
coimmunoprecipitations and chromatin 
immunoprecipitation assays, the authors 
find that XFDL156 binds to p53 and 
reduces its affinity for target promoters 
in vivo.
Understanding how cells integrate a 
handful of signaling pathways to unfurl 
distinct cellular differentiation programs 
is a critical challenge in developmental 
biology and medicine. A case in point 
is the intersection between fibroblast 
growth factor (FGF) and TGF-β signals. 
In embryos, FGFs are required for meso-
derm development, acting in concert with 
TGF-β (Niehrs, 2004). For these effects, 
FGF is a positive effector of Smad activ-
ity, but remarkably this is attained only 
through an indirect mechanism: MAPK 
activity promotes p53 phosphorylation, 
and this enables a robust p53/Smad 
interaction in the marginal zone of the 
embryo (Cordenonsi et al., 2007). In con-
trast, within the ectoderm, FGF/MAPK 
directly inhibits Smads by triggering an 
inhibitory phosphorylation in the middle 
region of Smad that promotes neural 
development (De Robertis, 2006). These 
observations could now be reconciled 
in light of the presence of this new fac-
tor restricted to ectoderm, XFDL156. By 
forestalling any p53 function in ectoderm, 
XFDL156 expression would confine FGF-
induced p53/Smad2 cooperation to the 
mesoderm while allowing the FGF/Smad 
inhibitory connection to prevail in the 
ectoderm.
Thus, an important theme emerg-
ing from the Sasai et al. report is that 
our current model of signaling cross-
talk for germ-layer specification needs 
to be revisited to take into account the 
temporal and spatial localization of p53 
transcriptional activity (Figure 1). The 
inhibition of p53 in ectoderm and activa-
tion in mesoderm, coupled to gradients 
of Smad activity along the embryonic 
poles, provides a simple but remarkably 
effective means to harmonize the pleio-
tropic functions of these signaling path-
ways in pluripotent embryonic cells.
Viewed from another perspective, 
the cloning of a p53 inhibitory protein 
that binds to the C terminus of p53 is 
intriguing, as it helps to shed light on a 
controversial aspect of p53 regulation. 
Indeed, the p53 C terminus appears 
inhibitory for p53 activity in 
most assays, and relief of 
this inhibition by acetylation 
or other events is considered 
a key activating step for p53 
tumor-suppressive functions, 
yet this domain is also critical 
for p53 function in other cel-
lular or experimental contexts 
(Ahn and Prives, 2001).
Perhaps the solution to 
these puzzling observations 
lies in the dynamic and likely 
dose- or context-specific 
interactions between p53 and 
the XFDL protein family. Sasai 
et al. show that XFDL156 inhi-
bition requires an intact p53 
C terminus. XFDL156 does 
not affect p53 C-terminal 
acetylation by the p300 
acetyltransferase; rather, it 
is the binding of XFDL156 to 
p53 that is modulated by p53 
C-terminal posttranslational 
modifications. Indeed, acety-
lation-mimicking (K to R) or acetylation-
resistant (K to Q) replacements in the 
p53 C terminus affect XFDL156 inhibi-
tion and lead to coherent changes in p53 
activity (up or down, respectively). Fur-
ther work is required to strengthen these 
ties and to attain a more mechanistically 
rich understanding of p53 activation by 
events that render its C terminus repul-
sive or attractive for binding to XFDL156. 
Given that cancer cells contain obligate 
and persistent p53-activating inputs, the 
search for the role of XFDL156 in tumors 
can now begin.
In sum, the Sasai et al. study leaves us 
with more open questions than answers. 
Are XFDL-related molecules required 
for p53 regulation in mammalian cells? 
Conversely, in addition to p53, do XFDL 
proteins also target p53 family mem-
bers p63 and p73? Does XFDL156 target 
mutant p53 (as expected, given that the 
C-terminal domain is never mutated in 
human tumors)? If so, is this truly a can-
didate oncogene or more like a tumor 
suppressor? Does this protein family 
regulate p53 in embryonic stem cells? Is 
the activity of XFDL156 under the control 
of additional extracellular cues? Reading 
the Sasai et al. paper raises the expecta-
tion that many intriguing stories are yet 
to come.
figure 1. p53 Regulation in germ-layer specification
TGFβ ligands, primarily Nodal, emanate from the endoderm (yellow) to induce 
overlying cells to become mesoderm (red). p53, turned on by FGF-mediated 
phosphorylation, is a required Smad partner in this process. In contrast, the 
ectoderm (blue) remains pluripotent well-beyond the beginning of gastrula-
tion. This is attained by controlling TGF-β through two temporally distinct 
mechanisms. Early on, the core TGF-β pathway is downregulated by Smad 
antagonists, such as ectodermin. Ectodermin/Tif1γ is an ectoderm-specific 
maternal determinant that ubiquitinates Smad4, inhibiting its activity (Dupont 
et al., 2005). In so doing, ectodermin neutralizes both BMP and TGF-β signal-
ing allowing ectoderm development and patterning. Later during gastrulation, 
the ectoderm expresses XFDL156, an inhibitor of p53 activity (Sasai et al., 
2008). This prevents p53-dependent responses (mesoderm induction) but 
leaves the core Smad pathway fully operational for distinct effects, namely 
germ-layer patterning along the dorsoventral (D-V) axis.768 Cell 133, May 30, 2008 ©2008 Elsevier Inc.
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ment 134, 3861–3872.How neural stem cells are regulated to 
ensure that the correct number and type of 
progeny are generated at the correct time 
is a fundamental question in neurobiology. 
Beyond improving our understanding of 
neurogenesis, the answer to this question 
may have a direct impact on the therapeu-
tic use of stem cell technology. In this issue 
of Cell, Maurange et al. (2008) uncover a 
temporal control mechanism in the neural 
stem cells of the Drosophila melanogaster 
larval central nervous system (CNS). This 
temporal control mechanism regulates the 
switch from early- to late-born neuronal 
cell fates in Drosophila larvae, eventually 
leading to either a terminal stem cell divi-
sion or programmed cell death. Remark-
ably, stalling Drosophila neural stem cells 
in an early temporal state resulted in con-
tinuously dividing stem cells that generate 
extra early-born neurons in the adult CNS. 
This observation is striking as neither neu-
ral stem cells nor neurogenesis are nor-
mally found in the adult fly.
During development, Drosophila neural 
stem cells (neuroblasts) divide asymmetri-
cally to self-renew and generate a ganglion 
mother cell (GMC) at each division. GMCs 
divide only once, producing two postmi-
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totic cells: either neurons or glia (Figure 1). 
Each neuroblast gives rise to distinct neu-
ronal cell types in an invariant order, much 
like the progenitor cells of the vertebrate 
cerebral cortex (Pearson and Doe, 2004). 
In the Drosophila embryo, neuroblast tem-
poral identity is governed by the sequen-
tial expression of the transcription factors 
Hunchback (Hb), Kruppel (Kr), Pou Domain 
protein (Pdm), and Castor (Cas). GMCs and 
their neuronal progeny maintain expres-
sion of the transcription factor transcribed 
at the time of their birth, thereby linking 
cell fate to birth order (Isshiki et al., 2001). 
The neuroblast transition from expressing 
Hb to expressing Kr, and the progression 
through later temporal states of develop-
ment, requires the expression of Seven 
up (Svp), a transcription factor belonging 
to the COUP-TF subgroup of the nuclear 
receptor family (Kanai et al., 2005). Fol-
lowing embryogenesis, Drosophila neuro-
blasts enter a period of quiescence before 
entering a second period of proliferation 
during the larval and pupal stages. Lar-
val neuroblasts are a powerful model for 
studying self-renewal and differentiation in 
the CNS. In particular, recent experiments 
in Drosophila have shown that misregula-
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tion of asymmetric cell division can lead 
to brain tumors (reviewed in Doe, 2008). 
However, the temporal control mecha-
nisms operating within the majority of 
postembryonic neuroblasts have not been 
identified so far.
Maurange et al. (2008) now find two dis-
tinct temporal subsets of neurons in the 
larval CNS. Early-born neurons are marked 
by expression of the BTB-zinc finger pro-
tein Chinmo, whereas smaller late-born 
neurons are marked by expression of the 
BTB-zinc finger protein Broad Complex 
(Br-C). Having identified the two temporal 
subsets of neurons, the authors sought to 
identify what regulates this switch in pro-
tein expression. The embryonic temporal 
regulator Cas is known to be re-expressed 
in larval neuroblasts (Almeida and Bray, 
2005). The authors find that, preceding the 
switch from neuronal Chinmo expression 
(Chinmo+) to Br-C expression (Br-C+),  lar-
val neuroblasts transiently re-expressed 
Cas, followed by expression of the tempo-
ral regulator Svp (Figures 1A and 1B).
Next, the researchers sought to inves-
tigate the role of these redeployed factors 
in the temporal identity of postembryonic 
neuroblasts, and in the Chinmo+ to Br-C+ 
neuroblasts
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